BioXcel LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-06 8:29 pm Sale | 2024-06-06 | 13D | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 8,830,622 23.500% | -674,023 (-7.09%) | Filing |
| 2023-09-28 5:00 pm Sale | 2023-09-19 | 13D | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 9,504,645 32.500% | -253,160 (-2.59%) | Filing |
| 2020-05-13 7:20 pm Purchase | 2018-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel LLC | 9,757,805 48.300% | 276,805 (+2.92%) | Filing |